Tactile Systems Technology (TCMD) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | -10.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.32% |
| Dec 31, 2025 | -11.57% |
| Sep 30, 2025 | -19.70% |
| Jun 30, 2025 | 10.74% |
| Mar 31, 2025 | 37.74% |
| Dec 31, 2024 | 54.62% |
| Sep 30, 2024 | 24.40% |
| Jun 30, 2024 | 16.46% |
| Mar 31, 2024 | 10.35% |
| Dec 31, 2023 | 178.32% |
| Sep 30, 2023 | 181.89% |
| Jun 30, 2023 | 170.72% |
| Mar 31, 2023 | 160.10% |
| Dec 31, 2022 | -22.32% |
| Sep 30, 2022 | 4.58% |
| Jun 30, 2022 | -52.35% |
| Mar 31, 2022 | -54.93% |
| Dec 31, 2021 | -41.01% |
| Sep 30, 2021 | -46.92% |
| Jun 30, 2021 | 56.37% |
| Mar 31, 2021 | 45.29% |
| Dec 31, 2020 | 110.17% |
| Sep 30, 2020 | 113.00% |
| Jun 30, 2020 | 25.16% |
| Mar 31, 2020 | 37.15% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | -14.36% |
| Jun 30, 2019 | 44.57% |
| Mar 31, 2019 | -6.97% |
| Dec 31, 2018 | -5.00% |
| Sep 30, 2018 | 17.72% |
| Jun 30, 2018 | -4.29% |
| Mar 31, 2018 | 22.20% |
| Dec 31, 2017 | -21.93% |
| Sep 30, 2017 | -49.98% |
| Jun 30, 2017 | 169.33% |
| Mar 31, 2017 | 257.94% |
| Dec 31, 2016 | 334.86% |
| Sep 30, 2016 | 592.77% |
| Jun 30, 2016 | 30.97% |